Table 2.
A summary of vital signs, laboratory testing, and use of antibiotics and vasopressors during the treatment period.
| Admission day | ||||||
|---|---|---|---|---|---|---|
| Indicators | 1 day | 2 days | 4 days | 6 days | 8 days | 12 days |
| WBC (×109/L) | 14.46 | 18.64 | 17.96 | 17.9 | 11.63 | 8.97 |
| PCT (μg/L) | 2.33 | 0.66 | 0.18 | 0.11 | 0.08 | 0.06 |
| CRP (mg/L) | 276.9 | 123.0 | 41.3 | 34.1 | 6.36 | 1.6 |
| D-D (mg/L) | 0.63 | 0.89 | 1.85 | 6.85 | 2.28 | 0.64 |
| BP (mmHg, 1 mmHg = 0.133 kPa) | 76/57 | 85/62 | 93/68 | 101/71 | 115/82 | 128/93 |
| Metaraminol dose | 0.3 mg/min | 0.2 mg/min | 0.2 mg/min | 0.1 mg/min | Withdrawal | Withdrawal |
| Antibiotics | Intravenous administration of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) | Intravenous administration of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) | Intravenous administration of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) | Intravenous administration of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) | Intravenous administrations of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) plus moxifloxacin (0.4 g, once a day, for 4 days) | Intravenous administrations of piperacillin sodium/sulbactam sodium (4.5 g, every 8 h, for 8 days) plus moxifloxacin (0.4 g, once a day, for 4 days) |
WBC, white blood cell; PCT, procalcitonin; CRP, C-reactive protein; D-D, D-dimer; BP, blood pressure.